Wed, Mar 4, 2015, 12:07 AM EST - U.S. Markets open in 9 hrs 23 mins

Recent

% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

chc1 8 posts  |  Last Activity: Feb 25, 2015 12:08 PM Member since: Dec 7, 1997
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • chc1 chc1 Feb 25, 2015 12:08 PM Flag

    For those who think they are smarter than Dr. Frost or Dr. Frost is just lucky, then this is the time to sell. You are a genius !! Let us know when you start up a company so we can all invest with you.

  • chc1 chc1 Feb 25, 2015 11:16 AM Flag

    I can just imagine Dr. Frost looking at the $15/sh stock price and saying to himself, "Ooooh... my company is trading at $15.sh... I'm so satisfied and I'm going to sell out now because that was my goal from the very start..." NOT !

  • Anyone selling OPK in the $14-$15 ranges is really NOT THINKING LIKE DR. FROST. Do you think Dr. Frost has the goal of selling at $15/sh?? Is that REALLY his mega exit plan?? Emphatically NO ! He is going to do what he has done with his other successful companies... get them primed to be bought up for HUGE GAIN !! Much bigger than $15/sh... I regret selling some shares at $14.40...

  • Reply to

    I'm out. And lost enough.

    by chc1 Feb 11, 2015 3:42 PM
    chc1 chc1 Feb 12, 2015 1:00 AM Flag

    I am and medical doctor with family members using electroporation in their lab at major university. The dream I hoped for was INO had a DNA vaccine that was so profoundly successful that there would be a race by other companies to configure their own DNA sequence vaccine to match INO... much like how companies raced to get their own Hep C drug out after GILD showed profound success. But INO did not show profound success. That made is foggy at best for other companies watching if INO's DNA vaccine concept was worth chasing... it is apparently not so far... Why bother spending time and money with their own variation of DNA sequenced vaccine if INO could not show game-changing effectiveness. Of course, if INO does eventually show game-changing effectiveness, then the race is on again... I'm just one that is moving on to other companies...

  • Reply to

    I'm out. And lost enough.

    by chc1 Feb 11, 2015 3:42 PM
    chc1 chc1 Feb 12, 2015 12:58 AM Flag

    I am and medical doctor with family members using electroporation in their lab at major university. The dream I hoped for was INO had a DNA vaccine that was so profoundly successful that there would be a race by other companies to configure their own DNA sequence vaccine to match INO... much like how companies raced to get their own Hep C drug out after GILD showed profound success. But INO did not show profound success. That made is foggy at best for other companies watching if INO's DNA vaccine concept was worth chasing... it is apparently not so far... Why bother spending time and money with their own variation of DNA sequenced vaccine if INO could not show game-changing effectiveness. Of course, if INO does eventually show game-changing effectiveness, then the race is on again... I'm just one that is moving on to other companies...

  • Reply to

    I'm out. And lost enough.

    by chc1 Feb 11, 2015 3:42 PM
    chc1 chc1 Feb 12, 2015 12:51 AM Flag

    Electroporation is actually commonly known and used in labs across major universities. It is not an exclusive right that belongs to INO or ONCS. A family member was a graduate student at UC San Diego (and yes, INO is well known in San Diego) who used electroporation to introduce vectors with DNA into cells. INO and ONCS may have patents, but the technology is not exclusive.

  • Reply to

    I'm out. And lost enough.

    by chc1 Feb 11, 2015 3:42 PM
    chc1 chc1 Feb 11, 2015 3:45 PM Flag

    Good luck to those who still have the strength and conviction to stay with INO. I hope it works out. I just think there are too many permutations of changing the DNA sequence which will still lead to a vaccine-immune response.

  • INO technology is flawed. They change the DNA sequence to create a vaccine against the offending cancer or virus. ANY COMPANY CAN DO THE SAME WITHOUT VIOLATING ANY PATENT. As long as the other company does not change the DNA exactly like INO, the subsequent DNA vaccine is a different patent. This is likely why big name companies backed out of partnership with INO. Thanks god I had OPK to more than make of for the loss.

INO
7.05-0.1200(-1.67%)Mar 3 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.